There is growing concern among scientists that inflammation caused by HIV and the side effects of some antiretroviral drugs, especially protease inhibitors, are increasing cardiovascular risk among people living with HIV. This was revealed during the fifth annual East African health and scientific conference held in Kampala last week. It was held under the theme; ‘Investing in health through strengthening regional health systems and institutions towards the prevention and control of communicable and non-communicable diseases.’ Cardiovascular diseases (CVDs) are heart and blood-vessel-related conditions, including hypertension, stroke, heart attacks and heart failure, among others and these account for nine per cent...